Drug Profile
Linotroban
Alternative Names: CL-871502; HN 11500Latest Information Update: 07 Sep 2006
Price :
$50
*
At a glance
- Originator Amersham
- Class Acetates; Antiplatelets; Small molecules; Thiophenes
- Mechanism of Action Thromboxane A2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 07 Sep 2006 Discontinued - Phase-II for Thrombosis in Austria (IV-injection)
- 07 Sep 2006 Discontinued - Phase-II for Thrombosis in Austria (PO)
- 13 Feb 1998 Suspended-II for Thrombosis in Austria (IV-injection)